Cancer‐associated fibroblast‐targeted strategy enhances antitumor immune responses in dendritic cell‐based vaccineYasuhiko Ohshio, Kazumasa Ogasawara, Yataro Daigo et al.|Cancer Science|2014Cited by 88
Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factorsTomoyuki Igarashi, Yataro Daigo, Jun Hanaoka et al.|ESMO Open|2016Cited by 80
Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancerKoji Teramoto, Yataro Daigo, Hidetoshi Sumimoto et al.|Lung Cancer|2019Cited by 59
Hypoxia‑induced galectin‑3 enhances RhoA function to activate the motility of tumor cells in non‑small cell lung cancerYoko Kataoka, Jun Hanaoka|Oncology Reports|2018Cited by 27
Predictive biomarkers and effectiveness of MUC1-targeted dendritic-cell-based vaccine in patients with refractory non-small cell lung cancerKoji Teramoto, Keiichi Kontani, Yoshitomo Ozaki et al.|Therapeutic Advances in Medical Oncology|2016Cited by 27